Skip to main content
Top
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Debate

Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening

Authors: David C Wheeler, Konrad M Szymanski, Amanda Black, David E Nelson

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

Despite the recent publication of results from two randomized clinical trials, prostate specific antigen (PSA) screening for prostate cancer remains a controversial issue. There is lack of agreement across studies that PSA screening significantly reduces prostate cancer mortality. In spite of these facts, the widespread use of PSA testing in the United States leads to overdetection and overtreatment of clinically indolent prostate cancer, and its associated harms of incontinence and impotence.

Discussion

Given the inconclusive results from clinical trials and incongruent PSA screening guidelines, the decision to screen for prostate cancer with PSA testing is an uncertain one for patients and health care providers. Screening guidelines from some health organizations recommend an informed decision making (IDM) or shared decision making (SDM) approach for deciding on PSA screening. These approaches aim to empower patients to choose among the available options by making them active participants in the decision making process. By increasing involvement of patients in the clinical decision-making process, IDM/SDM places more of the responsibility for a complex decision on the patient. Research suggests, however, that patients are not well-informed of the harms and benefits associated with prostate cancer screening and are also subject to an assortment of biases, emotion, fears, and irrational thought that interferes with making an informed decision. In response, the IDM/SDM approaches can be augmented with strategies from the philosophy of libertarian paternalism (LP) to improve decision making. LP uses the insights of behavioural economics to help people better make better choices. Some of the main strategies of LP applicable to PSA decision making are a default decision rule, framing of decision aids, and timing of the decision. In this paper, we propose that applying strategies from libertarian paternalism can help with PSA screening decision-making.

Summary

Our proposal to augment IDM and SDM approaches with libertarian paternalism strategies is intended to guide patients toward a better decision about testing while maintaining personal freedom of choice. While PSA screening remains controversial and evidence conflicting, a libertarian-paternalism influenced approach to decision making can help prevent the overdiagnosis and overtreatment of prostate cancer.
Literature
2.
go back to reference Andriole G, Crawford E, Grubb R, Buys S, Chia D, Church T, et al: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, 360 (13): 1310-1319. 10.1056/NEJMoa0810696.CrossRefPubMedPubMedCentral Andriole G, Crawford E, Grubb R, Buys S, Chia D, Church T, et al: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, 360 (13): 1310-1319. 10.1056/NEJMoa0810696.CrossRefPubMedPubMedCentral
3.
go back to reference Schröder F, Hugosson J, Roobol M, Tammela T, Ciatto S, Nelen V, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, 360 (13): 1320-1328. 10.1056/NEJMoa0810084.CrossRefPubMed Schröder F, Hugosson J, Roobol M, Tammela T, Ciatto S, Nelen V, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, 360 (13): 1320-1328. 10.1056/NEJMoa0810084.CrossRefPubMed
4.
go back to reference Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl C, Stranne J, Holmberg E, Lilja H: Mortality results from the Goteborg randomized population-based prostate-cancer screening trial. Lancet Oncol. 2010, 11: 725-732. 10.1016/S1470-2045(10)70146-7.CrossRefPubMedPubMedCentral Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl C, Stranne J, Holmberg E, Lilja H: Mortality results from the Goteborg randomized population-based prostate-cancer screening trial. Lancet Oncol. 2010, 11: 725-732. 10.1016/S1470-2045(10)70146-7.CrossRefPubMedPubMedCentral
5.
go back to reference Stark J, Mucci L, Rothman K, Adami H: Screening for prostate cancer remains controversial. BMJ. 2009, 339: 784-786.CrossRef Stark J, Mucci L, Rothman K, Adami H: Screening for prostate cancer remains controversial. BMJ. 2009, 339: 784-786.CrossRef
6.
go back to reference American Urological Association Education and Research Inc: Prostate-Specific Antigen Best Practice Statement: 2009 Update. 2009 American Urological Association Education and Research Inc: Prostate-Specific Antigen Best Practice Statement: 2009 Update. 2009
7.
go back to reference US Preventative Services Task Force: Screening for prostate cancer. U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008, 149: 185-191.CrossRef US Preventative Services Task Force: Screening for prostate cancer. U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008, 149: 185-191.CrossRef
8.
go back to reference Wolf A, Wender R, Etzioni R, Thompson I, D'Amico A, Volk R, et al: American Cancer Society guideline for the early detection of prostate cancer. CA Cancer J Clin. 2010, 60: 70-98. 10.3322/caac.20066.CrossRefPubMed Wolf A, Wender R, Etzioni R, Thompson I, D'Amico A, Volk R, et al: American Cancer Society guideline for the early detection of prostate cancer. CA Cancer J Clin. 2010, 60: 70-98. 10.3322/caac.20066.CrossRefPubMed
9.
go back to reference Deber R: Shared decision making in the real world. J Gen Intern Med. 1996, 11: 377-378. 10.1007/BF02600052.CrossRefPubMed Deber R: Shared decision making in the real world. J Gen Intern Med. 1996, 11: 377-378. 10.1007/BF02600052.CrossRefPubMed
10.
go back to reference Wennberg J: Shared decision making and the future of managed care. Disease Management and Clinical Outcomes. 1997, 1: 15-16.CrossRef Wennberg J: Shared decision making and the future of managed care. Disease Management and Clinical Outcomes. 1997, 1: 15-16.CrossRef
11.
go back to reference Volk R, Spann S: Decision-aids for prostate cancer screening. J Fam Pract. 2000, 49 (5): 425-427.PubMed Volk R, Spann S: Decision-aids for prostate cancer screening. J Fam Pract. 2000, 49 (5): 425-427.PubMed
12.
go back to reference Barry M, Cherkin D, Chang Y, Fowler F, Skates S: A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia. Disease Management and Clinical Outcomes. 1997, 1: 5-14.CrossRef Barry M, Cherkin D, Chang Y, Fowler F, Skates S: A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia. Disease Management and Clinical Outcomes. 1997, 1: 5-14.CrossRef
13.
go back to reference Volk R, Cass A, Spann S: A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999, 8: 333-340. 10.1001/archfami.8.4.333.CrossRefPubMed Volk R, Cass A, Spann S: A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999, 8: 333-340. 10.1001/archfami.8.4.333.CrossRefPubMed
14.
go back to reference Schapira M, Vanruiswyk J: The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract. 2000, 49: 418-424.PubMed Schapira M, Vanruiswyk J: The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract. 2000, 49: 418-424.PubMed
15.
go back to reference van Vugt H, Roobol M, Venderbos L, Joosten-van Zwanenburg E, Essink-Bot M, Steyerberg E, Bangma C, Korfage I: Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator. European Journal of Cancer. 2010, 46: 669-677. 10.1016/j.ejca.2009.11.022.CrossRefPubMed van Vugt H, Roobol M, Venderbos L, Joosten-van Zwanenburg E, Essink-Bot M, Steyerberg E, Bangma C, Korfage I: Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator. European Journal of Cancer. 2010, 46: 669-677. 10.1016/j.ejca.2009.11.022.CrossRefPubMed
16.
go back to reference Barry M: Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002, 136: 127-135.CrossRefPubMed Barry M: Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002, 136: 127-135.CrossRefPubMed
17.
go back to reference Wolf A, Nasser J, Wolf A, Schorling J: The impact of informed consent of patient interest in prostate-specific antigen screening. Arch Intern Med. 1996, 156: 1333-1336. 10.1001/archinte.156.12.1333.CrossRefPubMed Wolf A, Nasser J, Wolf A, Schorling J: The impact of informed consent of patient interest in prostate-specific antigen screening. Arch Intern Med. 1996, 156: 1333-1336. 10.1001/archinte.156.12.1333.CrossRefPubMed
18.
go back to reference Flood A, Wennberg J, Nease RJ, Fowler FJ, Ding J, Hynes L: The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996, 11: 342-349. 10.1007/BF02600045.CrossRefPubMed Flood A, Wennberg J, Nease RJ, Fowler FJ, Ding J, Hynes L: The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996, 11: 342-349. 10.1007/BF02600045.CrossRefPubMed
19.
go back to reference Frosch D, Kaplan R, Felitti V: The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001, 16: 391-398. 10.1046/j.1525-1497.2001.016006391.x.CrossRefPubMedPubMedCentral Frosch D, Kaplan R, Felitti V: The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001, 16: 391-398. 10.1046/j.1525-1497.2001.016006391.x.CrossRefPubMedPubMedCentral
20.
go back to reference Barry M, Wescott P, Reifler E, Chang Y, Moulton B: Reactions of potential jurors to a hypothetical malpractice suit: alleging failure to perform a prostate-specific antigen test. J Law Med Ethics. 2008, 36 (2): 396-402. 10.1111/j.1748-720X.2008.00283.x.CrossRefPubMed Barry M, Wescott P, Reifler E, Chang Y, Moulton B: Reactions of potential jurors to a hypothetical malpractice suit: alleging failure to perform a prostate-specific antigen test. J Law Med Ethics. 2008, 36 (2): 396-402. 10.1111/j.1748-720X.2008.00283.x.CrossRefPubMed
21.
go back to reference Moulton B, King J: Aligning ethics with medical decision-making: the quest for informed patient choice. J Law Med Ethics. 2010, 38 (1): 85-97. 10.1111/j.1748-720X.2010.00469.x.CrossRefPubMed Moulton B, King J: Aligning ethics with medical decision-making: the quest for informed patient choice. J Law Med Ethics. 2010, 38 (1): 85-97. 10.1111/j.1748-720X.2010.00469.x.CrossRefPubMed
22.
go back to reference Rimer B, Briss P, Zeller P, Chan E, Woolf S: Informed decision making: what is its role in cancer screening?. Cancer. 2004, 101 (5 Suppl): 1214-1228.CrossRefPubMed Rimer B, Briss P, Zeller P, Chan E, Woolf S: Informed decision making: what is its role in cancer screening?. Cancer. 2004, 101 (5 Suppl): 1214-1228.CrossRefPubMed
23.
go back to reference Hoffman R, Couper M, Zikmund-Fisher B, Levin C, McNaughton-Collins M, Helitzer D, et al: Prostate cancer screening decisions. Arch Intern Med. 2009, 169: 1611-1618. 10.1001/archinternmed.2009.262.PubMed Hoffman R, Couper M, Zikmund-Fisher B, Levin C, McNaughton-Collins M, Helitzer D, et al: Prostate cancer screening decisions. Arch Intern Med. 2009, 169: 1611-1618. 10.1001/archinternmed.2009.262.PubMed
24.
go back to reference O'Dell K, Volk R, Cass A, Spann S: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?. J Fam Pract. 1999, 48 (9): 679-681. O'Dell K, Volk R, Cass A, Spann S: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?. J Fam Pract. 1999, 48 (9): 679-681.
25.
go back to reference Arkes H: The psychology of patient decision making. Symptom Research: Methods and Opportunities. Edited by: Max M, Lynn J. 2003, National Institutes of Health Arkes H: The psychology of patient decision making. Symptom Research: Methods and Opportunities. Edited by: Max M, Lynn J. 2003, National Institutes of Health
26.
go back to reference Sunstein C, Thaler R: Libertarian paternalism is not an oxymoron. The University of Chicago Law Review. 2003, 70 (4): 1159-1202. 10.2307/1600573.CrossRef Sunstein C, Thaler R: Libertarian paternalism is not an oxymoron. The University of Chicago Law Review. 2003, 70 (4): 1159-1202. 10.2307/1600573.CrossRef
27.
go back to reference Tversky A, Kahneman D: The framing of decisions and the psychology of choice. Science. 1981, 211: 453-458. 10.1126/science.7455683.CrossRefPubMed Tversky A, Kahneman D: The framing of decisions and the psychology of choice. Science. 1981, 211: 453-458. 10.1126/science.7455683.CrossRefPubMed
28.
go back to reference Walter L, Bertenthal D, Lindquist K, Konety B: PSA screening among elderly men with limited life expectancies. JAMA. 2006, 296 (19): 2336-2342. 10.1001/jama.296.19.2336.CrossRefPubMed Walter L, Bertenthal D, Lindquist K, Konety B: PSA screening among elderly men with limited life expectancies. JAMA. 2006, 296 (19): 2336-2342. 10.1001/jama.296.19.2336.CrossRefPubMed
29.
go back to reference Chan E, Sulmasy D: What should men know about prostate-specific antigen screening before giving informed consent?. Am J Med. 1998, 105: 266-274. 10.1016/S0002-9343(98)00257-5.CrossRefPubMed Chan E, Sulmasy D: What should men know about prostate-specific antigen screening before giving informed consent?. Am J Med. 1998, 105: 266-274. 10.1016/S0002-9343(98)00257-5.CrossRefPubMed
30.
go back to reference Laine C, Davidoff F, Lewis C, Nelson E, Nelson E, Kessler R, et al: Important elements of outpatient care: a comparison of patients' and physicians' opinions. Ann Intern Med. 1996, 125: 640-645.CrossRefPubMed Laine C, Davidoff F, Lewis C, Nelson E, Nelson E, Kessler R, et al: Important elements of outpatient care: a comparison of patients' and physicians' opinions. Ann Intern Med. 1996, 125: 640-645.CrossRefPubMed
31.
go back to reference Ransohoff D, McNaughton Collins M, Fowler FJ: Why is prostate cancer screening so common when the evidence is so uncertain? a system without negative feedback. The American Journal of Medicine. 2002, 113: 663-667. 10.1016/S0002-9343(02)01235-4.CrossRefPubMed Ransohoff D, McNaughton Collins M, Fowler FJ: Why is prostate cancer screening so common when the evidence is so uncertain? a system without negative feedback. The American Journal of Medicine. 2002, 113: 663-667. 10.1016/S0002-9343(02)01235-4.CrossRefPubMed
32.
go back to reference Barry M: Involving patients in medical decisions: how can physicians do better?. JAMA. 1999, 282: 2356-2357. 10.1001/jama.282.24.2356.CrossRefPubMed Barry M: Involving patients in medical decisions: how can physicians do better?. JAMA. 1999, 282: 2356-2357. 10.1001/jama.282.24.2356.CrossRefPubMed
33.
go back to reference Thaler R, Sunstein C: Nudge: Improving Decisions about Health, Wealth, and Happiness. 2008, New York: Penguin Group Thaler R, Sunstein C: Nudge: Improving Decisions about Health, Wealth, and Happiness. 2008, New York: Penguin Group
34.
go back to reference Lowenstein G, Brennan T, Volpp K: Asymmetric paternalism to improve heath behaviors. JAMA. 2007, 298: 2415-2417. 10.1001/jama.298.20.2415.CrossRef Lowenstein G, Brennan T, Volpp K: Asymmetric paternalism to improve heath behaviors. JAMA. 2007, 298: 2415-2417. 10.1001/jama.298.20.2415.CrossRef
35.
go back to reference Halpern S, Ubel P, Asch D: Harnessing the power of default options to improve health care. N Engl J Med. 2007, 357: 1340-1344. 10.1056/NEJMsb071595.CrossRefPubMed Halpern S, Ubel P, Asch D: Harnessing the power of default options to improve health care. N Engl J Med. 2007, 357: 1340-1344. 10.1056/NEJMsb071595.CrossRefPubMed
36.
go back to reference Arkes H, Dawson N, Speroff T, Harrell FJ, Alzola C, Phillips R, Desbiens N, Oye R, Knaus W, Conners AJ: The covariance decomposition of the probability score and its use in evaluating prognostic estimates. SUPPORT Investigators. Med Decis Making. 1995, 15 (2): 120-131.CrossRefPubMed Arkes H, Dawson N, Speroff T, Harrell FJ, Alzola C, Phillips R, Desbiens N, Oye R, Knaus W, Conners AJ: The covariance decomposition of the probability score and its use in evaluating prognostic estimates. SUPPORT Investigators. Med Decis Making. 1995, 15 (2): 120-131.CrossRefPubMed
37.
go back to reference Ward J, Hughes A, Hirst G, Winchester L: Men's estimates of prostate cancer risk and self-reported rates of screening. The Medical Journal of Australia. 1997, 167: 250-253.PubMed Ward J, Hughes A, Hirst G, Winchester L: Men's estimates of prostate cancer risk and self-reported rates of screening. The Medical Journal of Australia. 1997, 167: 250-253.PubMed
38.
go back to reference Rai T, Clements A, Bukach C, et al: What influences men's decision to have a prostate-specific antigen test? A qualitative study. Fam Pract. 2007, 24 (4): 365-371. 10.1093/fampra/cmm033.CrossRefPubMed Rai T, Clements A, Bukach C, et al: What influences men's decision to have a prostate-specific antigen test? A qualitative study. Fam Pract. 2007, 24 (4): 365-371. 10.1093/fampra/cmm033.CrossRefPubMed
40.
go back to reference Albertsen P: PSA testing: public policy or private penchant?. JAMA. 2006, 296 (19): 2371-2373. 10.1001/jama.296.19.2371.CrossRefPubMed Albertsen P: PSA testing: public policy or private penchant?. JAMA. 2006, 296 (19): 2371-2373. 10.1001/jama.296.19.2371.CrossRefPubMed
41.
go back to reference Choi J, Laibson D, Madrian B, Metrick A: Saving for retirement on the path of least resistance. Behavioral Public Finance. Edited by: McCaffery E, Slemrod J. 2006, New York: Russell Sage Choi J, Laibson D, Madrian B, Metrick A: Saving for retirement on the path of least resistance. Behavioral Public Finance. Edited by: McCaffery E, Slemrod J. 2006, New York: Russell Sage
42.
go back to reference Madrian B, Shea D: The power of suggestion: inertia in 401(k) participation and savings behavior. Quarterly Journal of Economics. 2001, 116: 1149-1225. 10.1162/003355301753265543.CrossRef Madrian B, Shea D: The power of suggestion: inertia in 401(k) participation and savings behavior. Quarterly Journal of Economics. 2001, 116: 1149-1225. 10.1162/003355301753265543.CrossRef
43.
go back to reference Johnson E, Goldstein D: Do defaults save lives?. Science. 2003, 302: 1338-1339. 10.1126/science.1091721.CrossRefPubMed Johnson E, Goldstein D: Do defaults save lives?. Science. 2003, 302: 1338-1339. 10.1126/science.1091721.CrossRefPubMed
44.
go back to reference Junghans C, Feder G, Hemingway H, Timmis A, Jones M: Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies. BMJ. 2005, 331: 940-942. 10.1136/bmj.38583.625613.AE.CrossRefPubMedPubMedCentral Junghans C, Feder G, Hemingway H, Timmis A, Jones M: Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies. BMJ. 2005, 331: 940-942. 10.1136/bmj.38583.625613.AE.CrossRefPubMedPubMedCentral
45.
go back to reference Courser M, Shamblen S, Lavrakas P, Collins D, Ditterline P: The impact of active consent procedures on nonresponse and nonresponse error in youth survey data: evidence from a new experiment. Eval Rev. 2009, 33: 370-395. 10.1177/0193841X09337228.CrossRefPubMedPubMedCentral Courser M, Shamblen S, Lavrakas P, Collins D, Ditterline P: The impact of active consent procedures on nonresponse and nonresponse error in youth survey data: evidence from a new experiment. Eval Rev. 2009, 33: 370-395. 10.1177/0193841X09337228.CrossRefPubMedPubMedCentral
46.
go back to reference Johnson E, Bellman S, Lohse G: Defaults, framing and privacy: why opting in-opting out. Marketing Letters. 2002, 13: 5-15. 10.1023/A:1015044207315.CrossRef Johnson E, Bellman S, Lohse G: Defaults, framing and privacy: why opting in-opting out. Marketing Letters. 2002, 13: 5-15. 10.1023/A:1015044207315.CrossRef
47.
go back to reference Briss P, Rodewald L, Hinman A, Shefer A, Strikas R, et al: Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000, 18 (1 Suppl): 97-140.CrossRefPubMed Briss P, Rodewald L, Hinman A, Shefer A, Strikas R, et al: Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000, 18 (1 Suppl): 97-140.CrossRefPubMed
48.
go back to reference Cornia P, Amory J, Fraser S, Saint S, Lipsky B: Computerbased order entry decreases duration of indwelling urinary catheterization in hospitalized patients. Am J Med. 2003, 114: 404-407. 10.1016/S0002-9343(02)01568-1.CrossRefPubMed Cornia P, Amory J, Fraser S, Saint S, Lipsky B: Computerbased order entry decreases duration of indwelling urinary catheterization in hospitalized patients. Am J Med. 2003, 114: 404-407. 10.1016/S0002-9343(02)01568-1.CrossRefPubMed
49.
go back to reference Gigerenzer G: Gut feelings: the intelligence of the unconscious. 2007, New York: Penguin Group Gigerenzer G: Gut feelings: the intelligence of the unconscious. 2007, New York: Penguin Group
50.
go back to reference Malenka D, Baron J, Johansen S, Wahrenberger J, Ross J: The framing effect of relative and absolute risk. J Gen Intern med. 1993, 8 (10): 543-548. 10.1007/BF02599636.CrossRefPubMed Malenka D, Baron J, Johansen S, Wahrenberger J, Ross J: The framing effect of relative and absolute risk. J Gen Intern med. 1993, 8 (10): 543-548. 10.1007/BF02599636.CrossRefPubMed
51.
go back to reference Bayer R, Fairchild A: Changing the paradigm for HIV testing - the end of exceptionalism. N Engl J Med. 2006, 355: 647-649. 10.1056/NEJMp068153.CrossRefPubMed Bayer R, Fairchild A: Changing the paradigm for HIV testing - the end of exceptionalism. N Engl J Med. 2006, 355: 647-649. 10.1056/NEJMp068153.CrossRefPubMed
Metadata
Title
Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening
Authors
David C Wheeler
Konrad M Szymanski
Amanda Black
David E Nelson
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-148

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine